Search results

1471 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Parents ranked cancer prevention as No. 1 provider reason for HPV vaccination
A survey led by UNC Lineberger's Melissa Gilkey, PhD, and collaborators found that parents ranked cancer prevention as the most compelling reason health care providers can give for recommending the human papillomavirus (HPV) vaccine.
Located in News / 2018 / June
Understanding the impact of heart attack type on hospital-level outcomes
New research in the Journal of the American Heart Association from a UNC team including Cardiology research fellow Dr. Sameer Arora and Cardiology faculty members Dr. Matt Cavender and Division Chief Dr. Rick Stouffer suggests that it may be of benefit to not categorize type 2 myocardial infarction (MI) under the general umbrella of non-ST-elevation myocardial infarction. The research suggests it may be better to differentiate it from type 1 MI patients clinically.
Located in Vital Signs / 2018 / June 14
Getting to the Heart of Congenital Cardiac Defects
UNC researchers led by Frank Conlon, PhD, shed light on how gene defects lead to congenital heart malformations.
Located in News / 2018 / June
UNC Lineberger among national leaders endorsing goal of eliminating HPV-related cancers in the US
The directors of the 70 National Cancer Institute-designated cancer centers, including UNC Lineberger Comprehensive Cancer Center, have issued a joint statement endorsing gender-neutral HPV vaccination and evidence-based cancer screening.
Located in News / 2018 / June
T cells alone are sufficient to establish and maintain HIV infection in the brain
Led by J. Victor Garcia, PhD, UNC researchers report in the Journal of Clinical Investigation that T cells in the brain may be an important HIV reservoir that should be targeted by HIV cure approaches.
Located in News / 2018 / June
More frequent screening after prostate cancer treatment not linked to improved survival
A study by UNC Lineberger's Ronald Chen, MD, MPH, and colleagues assessed whether monitoring prostate cancer patients following treatment with a PSA test every three months versus once a year would provide a long-term survival benefit.
Located in News / 2018 / June
Blood mutations could contaminate genetic analyses of tumors
UNC Lineberger Comprehensive Cancer Center researchers and colleagues led by Catherine C. Coombs, MD, show that blood cell mutations accounted for as many as 8 percent of the mutations identified in large-scale genetic sequencing efforts at two major academic centers.
Located in News / 2018 / June
New patent on autism genetic test could stall scientific research
Jim Evans, MD, PhD, was quoted in The Scientist on the potential of a North Carolina-based company charging a licensing fee to scientists who want to sequence the gene HOMER1, which has been linked to autism.
Located in Vital Signs / 2018 / June 1
Genetic Testing for Statin Therapy Not Cost-Effective
Research led by UNC School of Medicine MD/PhD student Jamie Jarmul, PhD, suggests physicians should defer to traditional 10-year risk score and existing statin guidelines in lieu of genetic tests.
Located in News / 2018 / May
Bae-Jump’s new research explores the origins of racial disparities in endometrial cancer
Victoria Bae-Jump, MD, PhD, was recently awarded grant funding totaling more than $800,000 to further her research on the underlying biological factors that may influence the development and mortality of endometrial cancer in both Caucasian and African-American women.
Located in News / 2018 / May